- PARTNERSHIPS
- 17 Feb 2026
Europe’s PFAS Rules Spur Water Tech Deals
Acquisition by Nijhuis Saur reflects race to meet EU drinking water limits due in 2026
Europe’s tightening rules on so-called “forever chemicals” are accelerating investment and consolidation in the water sector, as utilities prepare to meet new binding limits that take effect in 2026.
Nijhuis Saur Industries has acquired a majority stake in French technology developer Coldep, strengthening its position in the market for PFAS treatment. The move comes ahead of the revised EU Drinking Water Directive, which requires member states to transpose and apply stricter limits on per- and polyfluoroalkyl substances by January 2026.
For the first time, the directive sets binding concentration thresholds for a group of PFAS in drinking water. Utilities across the bloc are therefore under pressure to upgrade monitoring systems and install treatment technologies capable of meeting the new standards.
Industry estimates suggest that Europe’s PFAS treatment market could be worth several billion euros over the coming decade, driven by compliance spending, industrial retrofits and rising public scrutiny. As deadlines approach, operators are seeking systems that offer measurable performance and long-term regulatory certainty.
Coldep has developed a separation technology designed to concentrate PFAS before final destruction or disposal. By reducing the volume of contaminated waste generated during treatment, the process aims to lower transport, disposal and energy costs, factors that weigh heavily on utilities managing full lifecycle compliance.
The acquisition supports Saur Group’s broader strategy of offering integrated water solutions that combine detection, removal, concentration and waste management. Executives have indicated that the technology could be deployed across municipal networks, desalination plants and industrial wastewater facilities.
Utilities are increasingly favouring comprehensive systems rather than standalone components. That shift reflects both regulatory complexity and financial caution, as operators seek solutions that will remain effective if standards tighten further.
With implementation of the Drinking Water Directive drawing closer, PFAS treatment is emerging as a central focus of European water investment. Transactions such as this suggest a market moving towards scale and integration in response to a clearly defined regulatory timetable.


